View Financial HealthBio Planet 배당 및 자사주 매입배당 기준 점검 2/6Bio Planet 수익으로 충분히 충당되는 현재 수익률 1.89% 보유한 배당금 지급 회사입니다. 다음 지급일은 18th September, 2026 이며 배당락일은 다음과 같습니다. 23rd June, 2026.핵심 정보1.9%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률-3.5%다음 배당 지급일18 Sep 26배당락일23 Jun 26주당 배당금n/a배당 성향6%최근 배당 및 자사주 매입 업데이트공시 • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.공시 • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).모든 업데이트 보기Recent updates공시 • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.공시 • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.공시 • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025공시 • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.공시 • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).공시 • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.공시 • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.공시 • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.공시 • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.예정된 배당 지급오늘May 25 2026배당락일Jun 23 2026배당 지급일Sep 18 202687 days (배당락일 기준)다음 배당금을 받으려면 앞으로 29 days일 이내에 매수하세요지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 8WS 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: 8WS 의 배당금 지급이 증가했지만 회사는 7 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장Bio Planet 배당 수익률 vs 시장8WS의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (8WS)1.9%시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Consumer Retailing)3.6%분석가 예측 (8WS) (최대 3년)n/a주목할만한 배당금: 8WS 의 배당금( 1.89% )은 German 시장에서 배당금 지급자의 하위 25%( 1.51% )보다 높습니다.고배당: 8WS 의 배당금( 1.89% )은 German 시장에서 배당금 지급자의 상위 25%( 4.55% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 낮은 배당금 지급 비율 (5.9%)로 인해 8WS의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 255.8% )이 높기 때문에 8WS 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 18:51종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bio Planet S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.
공시 • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.
Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).
공시 • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.
공시 • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.
공시 • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025
공시 • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.
New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).
New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.
공시 • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).
New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).
Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).
New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).
New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
공시 • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.
Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).
Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.
공시 • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.
공시 • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.
Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.
Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.
공시 • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.